Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /DIVISLAB
chevron_leftBack

Divi's Laboratories Ltd.

DIVISLAB
NSE: DIVISLAB Delayed
5,924.50INR 0.2%
69.29 USD
As of 24 April 2025, Divi's Laboratories Ltd. has a market cap of $18.37B USD, ranking #1009 globally and #53 in India. It ranks #85 in the Healthcare sector, and #7 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
1009
Country Rank
53
Sector Rank
85
Industry Rank
7
Key Stats
Market Cap
$18.37BUSD
1.57T INR
Enterprise Value
$17.93BUSD
1.53T INR
Revenue (TTM)
$1.06BUSD
90.78B INR
EBITDA (TTM)
$331.0MUSD
28.3B INR
Net Income (TTM)
$241.97MUSD
20.67B INR
EBITDA Margin
31%
Profit Margin
23%
PE Ratio
75.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kiran Divi open_in_new
Employees
9,741
Founded
1990
Website
divislabs.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.2% 3.1% 2% 1.6% -0.2% 61%
Upcoming Earnings
Earnings Date
Fri, May 23

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
DIVISLAB
Divi's Laboratories Ltd
ISIN: INE361B01024
Shares Out.:
265.469M1 Shares Float: 126.676M2
TV:
SA:
YF:
GF:
BA:
MS:
5.92K INR
Bombay Stock Exchange
MIC: XBOM
532488 (DIVISLAB)
Divi's Laboratories Ltd
ISIN: INE361B01024
TV:
SA:
YF:
GF:
BA:
MS:
5.64K INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Divi's Laboratories Ltd.

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.08B
4.19T INR
167%
Cipla Ltd.
CIPLA
$14.45B
1.23T INR
-21%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.21B
1.13T INR
-28%
Mankind Pharma Ltd.
MANKIND
$12.46B
1.06T INR
-32%
Dr. Reddy's Laboratories Ltd.
DRREDDY
$11.46B
978.83B INR
-38%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
266%
Merck KGaA
MRK
$59.42B
52.43B EUR
223%
Takeda Pharmaceutical Company Ltd.
4502
$46.11B
6.6T JPY
151%
Haleon plc
HLN
$45.57B
34.34B GBP
148%
Galderma Group AG
GALD
$23.06B
19.13B CHF
26%